Old Web
English
Sign In
Acemap
>
authorDetail
>
James Michael Siedlecki
James Michael Siedlecki
Cancer immunotherapy
Immune system
Immunology
Antibody-dependent cell-mediated cytotoxicity
Immunotherapy
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
2015
Journal for ImmunoTherapy of Cancer
Isabelle Sansal-Castellano
Mark Carlson
Gabriel Oscar Reznik
James Michael Siedlecki
John Kane
Zuzana Dostalova
Hua Miao
Ifat Rubin-Bejerano
Show All
Source
Cite
Save
Citations (0)
Β-1,6-d-glucanes immunomodulateurs
2015
James Michael Siedlecki
Gabriel Oscar Reznik
John James Kane
Hua Miao
Arthur F. Kluge
Ifat Rubin-Bejerano
Show All
Source
Cite
Save
Citations (0)
mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils
2014
Journal for ImmunoTherapy of Cancer
Ifat Rubin-Bejerano
Isabelle Sansal-Castellano
Mark Carlson
Gabriel Oscar Reznik
James Michael Siedlecki
John Kane
Zuzana Dostalova
Hua Miao
Show All
Source
Cite
Save
Citations (0)
1